All Stories

  1. Emerging molecular diagnostics in personalized medicine
  2. Nanoparticle-based rapid point-of-care platform for methicillin-resistant Staphylococcus aureus
  3. The Correlation of Radiogenomics and Green Tea Extract Polyphenols: Redefining Head and Neck Cancer Management
  4. Perillyl alcohol-inclusion complex encapsulated electrospun gum arabic/PVA nanofiber for active fruit packaging
  5. Farnesol functionalized chitosan-gold nanocomposites for disruption of fungal biofilms
  6. In Silico and In Vitro Potential Antifungal Insights of Insect-Derived Peptides in the Management of Candida sp. Infections
  7. Pharmacological Benefits of Cinnamaldehyde: A Comprehensive Insight
  8. Biochemical insights into synergistic Candida biofilm disintegrating ability of p-cymene inclusion complex and miconazole
  9. Design, synthesis and physicochemical characterization of lysozyme stabilized silver nanocatalyst for degradation of hazardous dyes
  10. Role of artificial intelligence in automating diagnostic procedures in clinical microbiology laboratories
  11. Management of Denture Stomatitis with a Herbal Armamentarium
  12. Microplastics in food: Occurrence, toxicity, green analytical detection methods and future challenges
  13. An update on the pathogenesis and ethnopharmacological therapeutic approaches of vulvovaginal candidiasis
  14. Lateral flow assays: Progress and evolution of recent trends in point-of-care applications
  15. Detailed investigation on FAME capped metal nanocomposite synthesis as potential antifungal agent
  16. Nanoformulations for dismantling fungal biofilms: The latest arsenals of antifungal therapy
  17. Tyrosol-gold nanoparticle functionalized acacia gum-PVA nanofibers for mitigation of Candida biofilm
  18. Assessing the synergistic potential of bacteriophage endolysins and antimicrobial peptides for eradicating bacterial biofilms
  19. Assessing the eradication potential of fungal biofilms using acacia gum/PVA nanofibers functionalized with geraniol-β cyclodextrin inclusion complex
  20. Vaccinomics
  21. The Cutaneous Barrier and Skin Infections
  22. Biochemical and metabolomic insights into antifungal mechanism of berberine against Candida glabrata
  23. Exploration of Antibiofilm and In Vivo Wound Healing Activity of p-Cymene-Loaded Gellan/PVA Nanofibers
  24. Progress in Fluorescence Biosensing and Food Safety towards Point-of-Detection (PoD) System
  25. Dissecting the molecular mechanisms of producing biofuel and value-added products by cadmium tolerant microalgae as sustainable biorefinery approach
  26. Biomaterial-based fibers for enhanced wound healing and effective tissue regeneration
  27. Overexpression of bacteriophage T4 and T7 endolysins differentially regulate the metabolic fingerprint of host Escherichia coli
  28. Insights into the extraction, characterization and antifungal activity of astaxanthin derived from yeast de-oiled biomass
  29. Elucidating the lactic acid tolerance mechanism in vaginal clinical isolates of Candida glabrata
  30. Plausible Mechanistic Insights in Biofilm Eradication Potential against Candida spp. Using In Situ-Synthesized Tyrosol-Functionalized Chitosan Gold Nanoparticles as a Versatile Antifouling Coating on Implant Surfaces
  31. Molecular investigations on Candida glabrata clinical isolates for pharmacological targeting
  32. Elucidating the Eradication Mechanism of Perillyl Alcohol against Candida glabrata Biofilms: Insights into the Synergistic Effect with Azole Drugs
  33. Eucalyptol/ β-cyclodextrin inclusion complex loaded gellan/PVA nanofibers as antifungal drug delivery system
  34. Eugenol-acacia gum-based bifunctional nanofibers as a potent antifungal transdermal substitute
  35. Plausible Mechanistic Insights in Biofilm Eradication Potential of against Candida spp. using In Situ Synthesized Tyrosol Functionalized Chitosan Gold Nanoparticles as a versatile Antifouling Coating on Implant Surfaces
  36. Geraniol eradicates Candida glabrata biofilm by targeting multiple cellular pathways
  37. Impact of Bacillus licheniformis SV1 Derived Glycolipid on Candida glabrata Biofilm
  38. Dissecting the therapeutic potency of antimicrobial peptides against microbial biofilms
  39. Dissecting the anti-biofilm potency of kappa-carrageenan capped silver nanoparticles against Candida species
  40. Cinnamaldehyde loaded nanofibers show excellent antifungal activity.
  41. Mechanistic insights into Candida biofilm eradication potential of eucalyptol
  42. Functional characterization of Candida glabrata ORF, CAGL0M02233g for its role in stress tolerance and virulence
  43. Microwave assisted κ-carrageenan capped silver nanocomposites for eradication of bacterial biofilms
  44. Chemistry and Biology of Farnesol and its Derivatives: Quorum Sensing Molecules with Immense Therapeutic Potential
  45. Role of Exopolysaccharides in Biofilm Formation
  46. Effectiveness of Phytoactive Molecules on Transcriptional Expression, Biofilm Matrix, and Cell Wall Components of Candida glabrata and Its Clinical Isolates
  47. Antagonistic Properties of Methanol Extract of Elaeocarpus sphaericus Leaves against in vitro Growth, Germ Tube Formation, Adhesion and Biofilm of Candida Species
  48. Functional analysis of selected deletion mutants in Candida glabrata under hypoxia
  49. Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), Inhibits Candida Biofilms: A Metabolomic Approach
  50. Antihypertensive, Amlodipine Besilate Inhibits Growth and Biofilm of Human Fungal Pathogen Candida
  51. Comparative effects of hypoxia and hypoxia mimetic cobalt chloride on in vitro adhesion, biofilm formation and susceptibility to amphotericin B of Candida glabrata